Parameters | Subacute phase | Subchronic phase | ||||
---|---|---|---|---|---|---|
Treatment group | Control | P value | Treatment group | Control | P value | |
Number of animals analyzed | 12 | 12 | 12 | 11 | ||
WBCs (× 103/μl) | 8.55 ± 2.12 | 8.23 ± 1.65 | 0.68 | 9.0 ± 1.96 | 8.03 ± 1.33 | 0.18 |
RBCs (× 106/μl) | 6.50 ± 0.68 | 6.31 ± 0.62 | 0.49 | 6.41 ± 0.51 | 6.21 ± 0.53 | 0.38 |
HGB (g/dl) | 12.56 ± 0.37 | 12.46 ± 0.74 | 0.68 | 12.52 ± 0.76 | 12.18 ± 0.50 | 0.22 |
HCT (%) | 36.56 ± 1.05 | 34.62 ± 4.73 | 0.19 | 33.25 ± 2.48 | 32.63 ± 2.81 | 0.58 |
MCV (fl) | 52.72 ± 4.03 | 52.18 ± 3.24 | 0.72 | 50.62 ± 1.77 | 50.24 ± 1.60 | 0.59 |
MCH (pg) | 20.52 ± 1.28 | 20.12 ± 1.98 | 0.56 | 19.71 ± 1.02 | 19.78 ± 1.29 | 0.89 |
MCHC (g/dl) | 37.15 ± 2.64 | 37.04 ± 2.36 | 0.91 | 38.94 ± 1.88 | 39.20 ± 1.68 | 0.73 |
PLT (103/μl) | 472.16 ± 29.44 | 471.31 ± 43.55 | 0.95 | 531.50 ± 125.49 | 545.0 ± 110.63 | 0.78 |
RDW (%) | 12.45 ± 1.01 | 12.65 ± 1.34 | 0.67 | 11.33 ± 0.92 | 11.03 ± 0.82 | 0.42 |
Reticulocytes (%) | 0.97 ± 0.43 | 1.04 ± 0.54 | 0.74 | 1.10 ± 0.22 | 1.04 ± 0.03 | 0.39 |